Please use this identifier to cite or link to this item: http://ricaxcan.uaz.edu.mx/jspui/handle/20.500.11845/2615
Full metadata record
DC FieldValueLanguage
dc.contributor46461es_ES
dc.contributor.otherhttps://orcid.org/0000-0001-6803-925X-
dc.contributor.otherhttps://orcid.org/0000-0002-2979-6159-
dc.coverage.spatialGlobales_ES
dc.creatorQuirarte Báez, Sol María-
dc.creatorZamora Perez, Ana Lourdes-
dc.creatorReyes Estrada, Claudia Araceli-
dc.creatorGutiérrez Hernández, Rosalinda-
dc.creatorSosa Macías, Martha-
dc.creatorGalaviz Hernández, Carlos-
dc.creatorGuerrero Manriquez, Gloria Guillermina-
dc.creatorLazaldo Ramos, Blanca Patricia-
dc.date.accessioned2021-06-18T17:17:56Z-
dc.date.available2021-06-18T17:17:56Z-
dc.date.issued2019-12-03-
dc.identifierinfo:eu-repo/semantics/publishedVersiones_ES
dc.identifier.issn2561-8741es_ES
dc.identifier.urihttp://ricaxcan.uaz.edu.mx/jspui/handle/20.500.11845/2615-
dc.identifier.urihttps://doi.org/10.48779/vg31-3k15-
dc.description.abstractBackground Rosemary leaves powder has been reported to reduce in a dose-dependent manner, glucose levels, lipid profile and lipid peroxidation in humans. However, patients should ingest high doses of powder contained in capsules. This formulation constitutes the intake of 10 capsules per day, so the active metabolite must first, be released and then absorbed (for which, rosemary leaf powder must be mixed with gastric juice). Aim Evaluate whether a shortened dose and time of treatment as well as the pharmaceutical presentation in rosemary tea (Rosmarinus officinalis) instead of powder have a therapeutic effect in the treatment of T2D. Method The complementary therapy with Rosemary tea (2g/1 litre of water per day) were evaluate on resistance to insulin, oxidative stress, biochemical parameters and anthropometric measurements in forty patients T2D under treatment with metformin and/or glibenclamide afther giving your authorization through informed consent.es_ES
dc.language.isoenges_ES
dc.publisherResearch Trentzes_ES
dc.relationhttps://jptcp.com/index.php/jptcp/article/view/634es_ES
dc.relation.ispartofhttps://doi.org/10.15586/jptcp.v26i4.634es_ES
dc.relation.urigeneralPublices_ES
dc.rightsAtribución-NoComercial-CompartirIgual 3.0 Estados Unidos de América*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.sourceJournal of Population Therapeutics and Clinical Pharmacology, Vol. 26 No. 4 (2019)es_ES
dc.subject.classificationBIOLOGIA Y QUIMICA [2]es_ES
dc.subject.otherRosemaryes_ES
dc.subject.otherresistance to insulines_ES
dc.subject.otheranthropometric parameterses_ES
dc.titleA shortened treatment with rosemary tea (rosmarinus officinalis) instead of glucose in patients with diabetes mellitus type 2 (TSD)es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
Appears in Collections:*Documentos Académicos*-- M. en Ciencias y Tecnología Química

Files in This Item:
File Description SizeFormat 
A shortened treatment with rosemary tea (rosmarinus officinalis) instead of.pdf749,29 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons